GGrantIndex
Sort

17,828 grants matching crispr

EAGER SENTINELS: The PCR-free Biosensor for a Fast, Simple, and Sensitive Detection of RNA.

$279,148
Artavazd Badalyan · Utah State University · · FY2021 · ENG

PDX tumor-TME acquired resistance

$279,123
Jack Roth · University Of California, San Francisco · U54 · FY2024 · CA

Triggering Innate Immunity in Tumor Cells to Overcome Resistance to Immunotherapy

$279,077
Jeffrey J. Ishizuka · Yale University · K08 · FY2023 · CA

Triggering Innate Immunity in Tumor Cells to Overcome Resistance to Immunotherapy

$279,077
Jeffrey J. Ishizuka · Yale University · K08 · FY2020 · CA

Triggering Innate Immunity in Tumor Cells to Overcome Resistance to Immunotherapy

$279,077
Jeffrey J. Ishizuka · Yale University · K08 · FY2021 · CA

Triggering Innate Immunity in Tumor Cells to Overcome Resistance to Immunotherapy

$279,077
Jeffrey J. Ishizuka · Yale University · K08 · FY2022 · CA

A cell-cycle induced genetic recorder for simultaneous recovery of cell divisions and lineage

$278,980
Ron Weiss · Massachusetts Institute Of Technology · R21 · FY2023 · CA

Identification of small molecules with selective cytotoxicity toward UGT3A2 KO cells

$278,962
Matthew Hall · National Center For Advancing Translational Sciences · ZIA · FY2025 · TR

THE ROLE OF COLLAGEN COL22A1 IN INTRACRANIAL ANEURYSMS AND VASCULAR STABILITY

$278,916
Saulius Sumanas · University Of South Florida · R01 · FY2020 · HL

miR-200 miRNAs repress tumor metastasis in lung adenocarcinoma

$278,388
Lin He · University Of California Berkeley · R01 · FY2020 · CA

Core F: Induced Pluripotent Stem Cell Core

$278,363
Mathew Mark Blurton-Jones · University Of California-Irvine · P30 · FY2021 · AG

Neural Stem Cell Based Virotherapy for Malignant Glioma

$278,358
Maciej S Lesniak · Northwestern University At Chicago · P50 · FY2023 · CA

Mechanisms of CRISPR Interference

$278,206
Erik J Sontheimer · Northwestern University · R01 · FY2010 · GM

Exploiting myeloma proteome remodeling to extend proteasome inhibitor efficacy

$278,183
Arun P. Wiita · University Of California, San Francisco · R01 · FY2022 · CA

Basic brain mechanisms underlying drug addiction, craving, and relapse

$278,046
Eliot Gardner · National Institute On Drug Abuse · ZIA · FY2018 · DA

Collaborative Research: TRTech-PGR: Optimization of Virus-based Delivery of Guide RNAs for Heritable Editing in Maize

$277,978
Myeong-Je Cho · University Of California-Berkeley · · FY2023 · BIO

Bioanalytic Core

$277,880
Mar M Sanchez · Emory University · P50 · FY2021 · MH

Genetic and Metabolic Determinants of Bacterial Interspecies Interactions

$277,851
Paul D. Straight · Texas A&M Agrilife Research · R01 · FY2023 · GM

Genetic and Metabolic Determinants of Bacterial Interspecies Interactions

$277,851
Paul D. Straight · Texas A&M Agrilife Research · R01 · FY2022 · GM

Genetic and Metabolic Determinants of Bacterial Interspecies Interactions

$277,851
Paul D. Straight · Texas A&M Agrilife Research · R01 · FY2024 · GM

Project 1: Targeting Metastatic Prostate Cancer Patients with Biallelic Loss of CDK12

$277,748
Arul M Chinnaiyan · University Of Michigan At Ann Arbor · P50 · FY2019 · CA

Epigenetic and microenvironmental regulation of dormant disseminated cancer

$277,249
Julio A Aguirre-Ghiso · Icahn School Of Medicine At Mount Sinai · R01 · FY2021 · CA

Genetics of stroke vulnerability in C57BL/6 mouse substrains

$277,187
Thaddeus S. Nowak · University Of Tennessee Health Sci Ctr · R01 · FY2024 · NS

MegaTALS: hyperspecific reagents for targeted gene modification and correction

$276,714
Barry L. Stoddard · Fred Hutchinson Cancer Center · R01 · FY2022 · GM

Early in vivo expressed antigens and their role in virulence, immune response, and vaccines for coccidioidomycosis

$276,453
Bridget Marie Barker · Northern Arizona University · U19 · FY2023 · AI